1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-139615 Sec61-IN-1

Others

Cancer

2021-10 Sec61-IN-1
HY-139553 Zunsemetinib

MAPKAPK2 (MK2)

Inflammation/Immunology

2021-10 Zunsemetinib
HY-111009 Swinholide A

Fungal

Infection

2021-10 Swinholide A
HY-139313 NHE3-IN-2

Sodium Channel

Metabolic Disease

2021-10 NHE3-IN-2
HY-P0208 [Leu31,Pro34]-Neuropeptide Y (porcine)

Neuropeptide Y Receptor

Neurological Disease

2021-10 [Leu31,Pro34]-Neuropeptide Y (porcine)
HY-108692 Enterolactone

Apoptosis; Endogenous Metabolite

Cancer

2021-10 Enterolactone
HY-131943 DS44960156

Others

Others

2021-10 DS44960156
HY-137456 Tilpisertib

Ser/Thr Protease

Cancer;

Inflammation/Immunology

2021-10 Tilpisertib
HY-137447 Pirepemat

Others

Neurological Disease

2021-10 Pirepemat
HY-P0062B Ziconotide acetate

Calcium Channel

Cardiovascular Disease;

Inflammation/Immunology

2021-10 Ziconotide acetate
HY-109146 Imifoplatin

Apoptosis

Cancer

2021-10 Imifoplatin
HY-137448 Rezvilutamide

Androgen Receptor

Cancer

2021-10 Rezvilutamide
HY-103712 Samuraciclib

CDK; Apoptosis

Cancer

2021-10 Samuraciclib
HY-101870 Uzansertib

Pim

Cancer

2021-10 Uzansertib
HY-137446 Mosliciguat

Guanylate Cyclase

Cardiovascular Disease

2021-10 Mosliciguat
HY-19923 Aganepag isopropyl

Prostaglandin Receptor

Endocrinology

2021-10 Aganepag isopropyl
HY-132810 Bevurogant

ROR

Inflammation/Immunology

2021-10 Bevurogant
HY-139555 Zectivimod

LPL Receptor

Inflammation/Immunology

2021-10 Zectivimod
HY-106093 Eltenac

COX

Inflammation/Immunology

2021-10 Eltenac
HY-P1292 PKG inhibitor peptide

Others

Cancer

2021-10 PKG inhibitor peptide